This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

103/Using transthoracic echocardiogram (TTE) to risk-stratify patients with inherited arrhythmia syndromes (IAS)

AI Iqbal (Presenting Author) and G Mellor – Royal Papworth Hospital, Cambridgeshire
2 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 9th 2012 European Journal of Arrhythmia & Electrophysiology. 2022;8(Suppl. 1):abstr103
Select a Section…
1

Article

Background: Electromechanical window (EMW) defines the difference between the end of mechanical systole and the termination of electrical repolarisation [EMW= QAoC – QT]. A negative EMW has been established in patients with long QT syndrome (LQTS) when compared with controls, with marked EMW negativity in symptomatic LQTS. EMW negativity has been shown to be a better risk-stratification tool compared with the existing methods.

Aims: To validate the findings of EMW negativity in LQTS and determine whether a negative EMW exists in other inherited arrhythmia syndromes (IAS) such as Brugada syndrome (BrS) and arrhythmogenic cardiomyopathy (ACM).

Method: This was a retrospective study at Royal Papworth Hospital, over a 10-year period (2011–2021), investigating a convenient sample size of LQTS (n=28), BrS (n=27), ACM (n=34) and control (normal; n=64). EMW was calculated as the difference between aortic valve closure QAoC and QT-interval measured using transthoracic echocardiography.

Results: A negative EMW was found in LQTS (-40 ± 50; p<0.001) and ACM (-10 ± 40; p<0.001) compared with controls. However, this was not true for the BrS cohort (17 ± 30; p=0.204). EMW was more negative in the symptomatic compared with the asymptomatic LQTS cohort. Both findings validate previous literature specifically that of a negative EMW (-43 ± 46 ms; p<0.0001) in LQTS compared with controls. LQTS type 3 had a marked EMW negativity compared with other LQTS types. A correlation existed between EMW negativity and a prolonged QT-interval. Excellent inter-rater reliability was established via the ICC calculation; average ICC was 0.97 with a confidence interval of 0.94–0.99.

Conclusions: LQTS and ACM cohorts had a negative EMW compared with controls, and EMW negativity was more pronounced in symptomatic LQTS. However, this was not the case in the BrS cohort. EMW has proven to outperform the traditionally used QTc and can be used when Bazett’s correction formula and wide QRS limit the use of QTc. Therefore, EMW negativity could be a useful measure of risk stratification in IAS.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup